Vincent Chung

Trials

Studies that name Vincent Chung as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:26 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06626256 · STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

  City of Hope Medical Center · withdrawn · Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma, Locally Advanced Malignant Solid Neoplasm · principal investigator
• N/A
  NCT06524973 · Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

  City of Hope Medical Center · recruiting · Metastatic Pancreatic Adenocarcinoma · principal investigator
• Ph1
  NCT06454383 · Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

  City of Hope Medical Center · active not recruiting · Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 · principal investigator
• Ph1
  NCT05227326 · AOH1996 for the Treatment of Refractory Solid Tumors

  City of Hope Medical Center · recruiting · Refractory Malignant Solid Neoplasm, Osteosarcoma, Leiomyosarcomas · principal investigator
• Ph2
  NCT04929392 · Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

  City of Hope Medical Center · active not recruiting · Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 · principal investigator
• Ph2
  NCT04887805 · Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

  City of Hope Medical Center · active not recruiting · Advanced Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8 · principal investigator
• Ph2
  NCT04548752 · Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

  National Cancer Institute (NCI) · active not recruiting · Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 · principal investigator
• N/A
  NCT04048603 · Search for Biomarkers of Neurodegenerative Diseases in Idiopathic REM Sleep Behavior Disorder

  Chinese University of Hong Kong · unknown · REM Sleep Behavior Disorder, Neurodegeneration · study director
• N/A
  NCT03671772 · Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD

  Chinese University of Hong Kong · completed · REM Sleep Behavior Disorder, Neurodegeneration · study director
• Ph1
  NCT02432963 · Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

  City of Hope Medical Center · active not recruiting · Adult Solid Neoplasm, Bladder Carcinoma, Colon Carcinoma · principal investigator
• Ph1
  NCT02336087 · Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

  City of Hope Medical Center · active not recruiting · Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 · principal investigator
• Ph1
  NCT02112565 · RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists

  City of Hope Medical Center · active not recruiting · Unspecified Adult Solid Tumor, Protocol Specific · principal investigator
• Ph1
  NCT01837667 · Phase I Study of LB-100 With Docetaxel in Solid Tumors

  Lixte Biotechnology Holdings, Inc. · completed · Tumors, Neoplasms, Cancer · principal investigator
• Ph1
  NCT01741597 · Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

  City of Hope Medical Center · withdrawn · Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Liver Metastases · principal investigator
• Ph2
  NCT01658943 · Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

  National Cancer Institute (NCI) · completed · Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma · principal investigator
• Ph1/Ph2
  NCT01231399 · Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer

  City of Hope Medical Center · completed · Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach · principal investigator
• Ph1
  NCT01191684 · Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

  City of Hope Medical Center · completed · Recurrent Colon Cancer, Recurrent Gastric Cancer, Recurrent Pancreatic Cancer · principal investigator
• Ph2
  NCT00544908 · Dasatinib in Treating Patients With Stage IV Pancreatic Cancer

  City of Hope Medical Center · terminated · Pancreatic Cancer · principal investigator
• Ph2
  NCT00538291 · Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

  City of Hope Medical Center · terminated · Colorectal Cancer · study chair
• Ph2
  NCT00538031 · Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

  City of Hope Medical Center · completed · Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2011 to 2026
  Named on NCT06626256, NCT06454383, NCT05227326, NCT04929392, NCT04887805, NCT00544908, NCT00538291
• SWOG Network Group Operations Center of the NCTN
  U10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAWN HERSHMAN, PRIMO N. LARA · fiscal years 2014 to 2026
  Named on NCT04548752, NCT01658943
• CEA TARGETED IMMUNOTHERAPEUTICS
  P01CA043904 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ANDREW A. RAUBITSCHEK · fiscal years 2011 to 2012
  Named on NCT01741597
• Southwest Oncology Group Treatment Grant
  U10CA032102 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHARLES D. BLANKE · fiscal years 2011 to 2013
  Named on NCT01658943